Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Targeting plasma kallikrein with a novel bicyclic peptide inhibitor (THR 149) reduces retinal inflammation and reactive gliosis in a diabetic rat model

Van Bergen, Tine - Euretina - 9-12 September 2021

Publication date: 
September, 2021